ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 118 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2017. The put-call ratio across all filers is 2.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $139,000 | -29.4% | 13,000 | 0.0% | 0.03% | -33.3% |
Q2 2020 | $197,000 | +82.4% | 13,000 | 0.0% | 0.04% | +50.0% |
Q1 2020 | $108,000 | -75.5% | 13,000 | -50.0% | 0.03% | -43.4% |
Q4 2019 | $440,000 | +82.6% | 26,000 | +100.0% | 0.05% | -10.2% |
Q3 2019 | $241,000 | -18.9% | 13,000 | 0.0% | 0.06% | -22.4% |
Q2 2019 | $297,000 | +8.8% | 13,000 | 0.0% | 0.08% | -1.3% |
Q1 2019 | $273,000 | +82.0% | 13,000 | 0.0% | 0.08% | +54.0% |
Q4 2018 | $150,000 | -49.7% | 13,000 | 0.0% | 0.05% | -43.8% |
Q3 2018 | $298,000 | +2.8% | 13,000 | 0.0% | 0.09% | -4.3% |
Q2 2018 | $290,000 | -51.2% | 13,000 | -50.0% | 0.09% | -5.1% |
Q1 2018 | $594,000 | +74.2% | 26,000 | +100.0% | 0.10% | -14.8% |
Q4 2017 | $341,000 | -41.6% | 13,000 | -50.0% | 0.12% | -0.9% |
Q3 2017 | $584,000 | -18.0% | 26,000 | 0.0% | 0.12% | -18.3% |
Q2 2017 | $712,000 | +13.0% | 26,000 | 0.0% | 0.14% | +7.6% |
Q1 2017 | $630,000 | +16.7% | 26,000 | 0.0% | 0.13% | +10.9% |
Q4 2016 | $540,000 | -23.7% | 26,000 | 0.0% | 0.12% | -28.3% |
Q3 2016 | $708,000 | – | 26,000 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 2,065,560 | $39,638,000 | 23.01% |
Selkirk Management LLC | 165,700 | $3,180,000 | 1.90% |
Opaleye Management Inc. | 100,000 | $1,919,000 | 0.97% |
LUCUS ADVISORS LLC | 80,000 | $1,535,000 | 0.68% |
Miura Global Management | 435,000 | $8,348,000 | 0.63% |
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 276,549 | $5,307,000 | 0.48% |
Iguana Healthcare Management, LLC | 50,000 | $960,000 | 0.46% |
BSW Wealth Partners | 22,714 | $436,000 | 0.35% |
Harvest Capital Strategies LLC | 90,000 | $1,727,000 | 0.19% |
FAIRFIELD, BUSH & CO. | 35,100 | $674,000 | 0.19% |